Use of FDG-PET in the differential diagnosis of a single bone lesion in ovarian cancer.
Leitha
Thomas
T
Department of Diagnostic and Therapeutic Nuclear Medicine, Danube Hospital, Vienna, Austria. Thomas.Leitha@smz.magwien.gv.at
Cesnik
Robert
R
Steiner
Erich
E
Frühwald
Franz
F
D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000556:secondary*; D003937:Diagnosis, Differential; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D010384:Pelvic Bones / Q000000981:diagnostic imaging* / Q000473:pathology; D010386:Pelvic Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000556:secondary; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013669:Technetium Tc 99m Medronate / Q000031:analogs & derivatives*
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; C024226:technetium Tc 99m hydroxymethylene diphosphonate; D013669:Technetium Tc 99m Medronate